EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)
Context Management of locally recurrent prostate cancer after definitive radiotherapy
remains controversial due to the perceived high rates of severe genitourinary (GU) and …
remains controversial due to the perceived high rates of severe genitourinary (GU) and …
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an …
A Pollack, TG Karrison, AG Balogh, LG Gomella… - The Lancet, 2022 - thelancet.com
Background In men with a detectable prostate-specific antigen (PSA) level after
prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in …
prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in …
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
CC Parker, NW Clarke, AD Cook, HG Kynaston… - The Lancet, 2020 - thelancet.com
Background The optimal timing of radiotherapy after radical prostatectomy for prostate
cancer is uncertain. We aimed to compare the efficacy and safety of adjuvant radiotherapy …
cancer is uncertain. We aimed to compare the efficacy and safety of adjuvant radiotherapy …
[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
[HTML][HTML] Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …
prostate cancer have improved outcomes, but there are still many aspects of management …
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …
P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre …
Background Molecular imaging is increasingly used to guide treatment decisions and
planning in prostate cancer. We aimed to evaluate the role of 18 F-fluciclovine-PET/CT in …
planning in prostate cancer. We aimed to evaluate the role of 18 F-fluciclovine-PET/CT in …
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
Background Nearly one-third of patients with prostate cancer (PCa) experience biochemical
recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant …
recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant …
Adjuvant versus early salvage radiation therapy for men at high risk for recurrence following radical prostatectomy for prostate cancer and the risk of death
PURPOSE Adjuvant compared with early salvage radiation therapy (sRT) following radical
prostatectomy (RP) has not been shown to reduce progression-free survival in randomized …
prostatectomy (RP) has not been shown to reduce progression-free survival in randomized …